Nucleic acid biosynthesis

"Nucleic acid biosynthesis" is not the name of a specific molecular target (such as a protein, receptor, or enzyme) but rather describes a biological process involving multiple enzymes and pathways responsible for the creation of nucleic acids like DNA and RNA[1][3][7]. Therefore, it is not a correct molecular target by scientific or pharmacological conventions. "Nucleic acid biosynthesis" is the process by which cells generate nucleic acids, primarily DNA and RNA, from nucleotide precursors[1][7]. This process involves a network of enzymatic reactions including the synthesis of purine and pyrimidine nucleotides, their phosphorylation, and their polymerization into nucleic acid chains by enzymes such as DNA and RNA polymerases. It is crucial for cellular division, genetic information storage, protein synthesis, and overall gene expression[4][6]. Many anticancer and antiviral drugs target individual enzymes within these pathways, but "nucleic acid biosynthesis" itself refers to a pathway, not a discrete molecular entity[5][7]. Targeting this process broadly can disrupt cell proliferation and is commonly exploited in oncology and infectious disease treatments. In summary, "nucleic acid biosynthesis" is a key cellular process, not a molecular target or receptor. For structured target analysis, refer instead to specific enzymes within this pathway, such as "thymidylate synthase," "ribonucleotide reductase," "DNA polymerase," etc.[8][7].

Inhibition of nucleotide biosynthesis; Incorporation of false nucleotides to disrupt chain elongation; Inhibition of DNA or RNA polymerases; Inhibition of topoisomerases